Delivery Order SPE2DB20D3101-SPE2DB23FRQS1

Award Date 6/30/23
Potential Completion Date 7/3/23
Potential Value $327
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $207,850 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pharmaceutical products. Under this order, Amerisourcebergen will provide 4562091921 MICARDIS HCT 40-12.5 MG TABLET UD 30S to the DLA from its facility in Conshohocken, Pennsylvania. The period of performance is September 8-11, 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, this order supports the DLA's mission to provide...
The Defense Logistics Agency awarded a $394,920 delivery order to Amerisourcebergen Drug Corporation for pharmaceutical products. Under this firm fixed price contract, Amerisourcebergen will provide 4561558621 MICARDIS HCT 40-12.5 MG TABLET UD 30S to the DLA from its facility in Conshohocken, Pennsylvania. The period of performance is July 20-21, 2023. As a major supplier of medical materiel to the Department of Defense, this order supports the DLA's mission to provide critical pharmaceuticals...
The Defense Logistics Agency awarded a $2,476.80 delivery order contract to Amerisourcebergen Drug Corporation for the supply of 4561889576 MICARDIS HCT 40-12.5 MG TABLET UD 30S. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the specified pharmaceutical product from its facility located in Conshohocken, Pennsylvania to fulfill DLA requirements. Performance will take place between August 21-22, 2023 under firm fixed pricing. As the DLA supports...
The Defense Logistics Agency awarded a $1,844.71 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561599443 MICARDIS HCT 40-12.5 MG TABLET UD 30S. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 25, 2023 through July 26, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency supports America's armed forces by providing...
The Defense Logistics Agency awarded a $3,634.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561623942 MICARDIS HCT 40-12.5 MG TABLET UD 30S. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 27, 2023 through July 28, 2023. As the DLA is responsible for worldwide logistics support of the U.S. Department of Defense, this delivery order was likely placed to support...
The Defense Logistics Agency awarded a $2,901 delivery order to Amerisourcebergen Drug Corporation for 4561836632 MICARDIS HCT 80-25 MG TABLET UD 30S. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide pharmaceutical products to DLA locations in Conshohocken, Pennsylvania from August 16-17, 2023. As a leading provider of pharmaceuticals and healthcare products, Amerisourcebergen will deliver the specified medications to support the...
The Defense Logistics Agency awarded a $249 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561771985 MICARDIS HCT 80-25 MG TABLET UD 30S. The order was issued under an existing DLA pharmaceuticals contract vehicle and will be performed by Amerisourcebergen at its facility in Conshohocken, Pennsylvania over a period of one day from August 10-11, 2023. No subcontractors or set aside designations were identified. The DLA manages the global supply chain...
The Defense Logistics Agency awarded a delivery order valued at approximately $2,227 to Amerisourcebergen Drug Corporation to supply 4561823960 MICARDIS HCT 40-12.5 MG TABLET UD 30S. The order was placed under an existing prime vendor contract held by Amerisourcebergen with DLA for pharmaceutical products. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania on a firm fixed price basis by August 16, 2023. No subcontractors or set aside designations were...
The Defense Logistics Agency awarded a $289.83 delivery order to Amerisourcebergen Drug Corporation for 4562043212 MICARDIS HCT 40-12.5 MG TABLET UD 30S. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products to DLA and the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period from September 5-6, 2023. The contract has a firm fixed price and no...
The Defense Logistics Agency awarded a $466.65 delivery order to Amerisourcebergen Drug Corporation for MICARDIS HCT 40-12.5 MG tablets. The firm fixed price order is to supply 30 tablets of the specified medication and will be performed by Amerisourcebergen at its facility in Conshohocken, Pennsylvania between July 3rd and July 5th, 2023. As a major provider of pharmaceuticals and medical supplies to the U.S. Department of Defense, this order for hypertension medication supports the DLA's...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRQS1
    Delivery Order

The Defense Logistics Agency awarded a $326,760 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pharmaceutical products. Under this order, Amerisourcebergen will supply 4561391954 MICARDIS HCT 80-12.5 MG TABLET UD 30S to the DLA from its facility in Conshohocken, Pennsylvania. The delivery order has a period of performance from June 30, 2023 through July 3, 2023. As the DLA's mission involves managing the global supply chain for the United States military, this order will help enable the Agency to provide needed pharmaceutical supplies to support military personnel, likely through the TRICARE health program.

Generated 12/16/23, 10:40 PM